相似文献
1
Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development.
Gastroenterology. 2019 Jan;156(2):338-354. doi: 10.1053/j.gastro.2018.06.093. Epub 2018 Sep 19.
2
A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
J Hepatol. 2017 Oct;67(4):669-679. doi: 10.1016/j.jhep.2017.05.010. Epub 2017 May 18.
3
Advances and Challenges in Studying Hepatitis B Virus In Vitro.
Viruses. 2016 Jan 14;8(1):21. doi: 10.3390/v8010021.
4
In Vitro Systems for Studying Different Genotypes/Sub-Genotypes of Hepatitis B Virus: Strengths and Limitations.
Viruses. 2020 Mar 23;12(3):353. doi: 10.3390/v12030353.
5
Animal models for the study of hepatitis B virus infection.
Zool Res. 2018 Jan 18;39(1):25-31. doi: 10.24272/j.issn.2095-8137.2018.013.
6
Small animal model systems for studying hepatitis B virus replication and pathogenesis.
Semin Liver Dis. 2006 May;26(2):181-91. doi: 10.1055/s-2006-939760.
7
[From the Establishment of Hepatitis B Virus Cell Culture Systems to Drug Discovery].
Yakugaku Zasshi. 2019;139(1):81-87. doi: 10.1248/yakushi.18-00164-4.
8
Mouse models of hepatitis B and delta virus infection.
J Immunol Methods. 2014 Aug;410:39-49. doi: 10.1016/j.jim.2014.03.002. Epub 2014 Mar 12.
9
Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
Hepatology. 2012 Mar;55(3):685-94. doi: 10.1002/hep.24758. Epub 2012 Jan 30.
10
Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection.
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13825-30. doi: 10.1073/pnas.202398599. Epub 2002 Oct 8.
引用本文的文献
1
The Evolution of Cell Culture Systems to Study Hepatitis B Virus Pathogenesis and Antiviral Susceptibility.
Viruses. 2025 Jul 29;17(8):1057. doi: 10.3390/v17081057.
2
Hepatitis B virus surface antigen drives T cell immunity through non-canonical antigen presentation in mice.
Nat Commun. 2025 May 17;16(1):4591. doi: 10.1038/s41467-025-59985-8.
3
Hepatitis B surface antigen hijacks TANK-binding kinase 1 to suppress type I interferon and induce early autophagy.
Cell Death Dis. 2025 Apr 15;16(1):304. doi: 10.1038/s41419-025-07605-0.
4
Therapeutic Nanomaterials in NAFLD: Current Advances and Potential Applications in Patients with Concurrent HBV Infection.
Int J Nanomedicine. 2025 Mar 25;20:3803-3823. doi: 10.2147/IJN.S510271. eCollection 2025.
5
Modeling of hepatitis B virus infection spread in primary human hepatocytes.
bioRxiv. 2025 Feb 7:2025.02.05.636596. doi: 10.1101/2025.02.05.636596.
6
Hepatitis B virus hijacks MRE11-RAD50-NBS1 complex to form its minichromosome.
PLoS Pathog. 2025 Jan 3;21(1):e1012824. doi: 10.1371/journal.ppat.1012824. eCollection 2025 Jan.
7
Long-term 3D cell culture models for hepatitis B virus studies.
Virology. 2024 Dec;600:110265. doi: 10.1016/j.virol.2024.110265. Epub 2024 Oct 18.
8
The feasibility of establishing a hamster model for HBV infection: evidence.
mBio. 2024 Nov 13;15(11):e0261524. doi: 10.1128/mbio.02615-24. Epub 2024 Sep 27.
9
The loss of hepatitis B virus receptor NTCP/SLC10A1 in human liver cancer cells is due to epigenetic silencing.
J Virol. 2024 Oct 22;98(10):e0118724. doi: 10.1128/jvi.01187-24. Epub 2024 Sep 19.
10
The Application of Organoids in the Study of Antiviral Innate Immunity.
Methods Mol Biol. 2025;2854:199-212. doi: 10.1007/978-1-0716-4108-8_20.
本文引用的文献
1
De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry.
Cell Chem Biol. 2018 Jul 19;25(7):906-915.e5. doi: 10.1016/j.chembiol.2018.04.011. Epub 2018 May 17.
2
A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction.
Biochem Biophys Res Commun. 2018 Jun 22;501(2):374-379. doi: 10.1016/j.bbrc.2018.04.187. Epub 2018 May 11.
3
Inhibitory effect of fasiglifam on hepatitis B virus infections through suppression of the sodium taurocholate cotransporting polypeptide.
Biochem Biophys Res Commun. 2018 Jun 27;501(3):820-825. doi: 10.1016/j.bbrc.2018.04.199. Epub 2018 May 4.
4
3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection.
Nat Commun. 2018 Feb 14;9(1):682. doi: 10.1038/s41467-018-02969-8.
5
Silencing Retinoid X Receptor Alpha Expression Enhances Early-Stage Hepatitis B Virus Infection In Cell Cultures.
J Virol. 2018 Mar 28;92(8). doi: 10.1128/JVI.01771-17. Print 2018 Apr 15.
6
Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays.
Antiviral Res. 2018 Apr;152:45-52. doi: 10.1016/j.antiviral.2018.02.007. Epub 2018 Feb 9.
7
A novel hepatitis B virus species discovered in capuchin monkeys sheds new light on the evolution of primate hepadnaviruses.
J Hepatol. 2018 Jun;68(6):1114-1122. doi: 10.1016/j.jhep.2018.01.029. Epub 2018 Feb 8.
8
Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide.
Sci Rep. 2018 Feb 9;8(1):2769. doi: 10.1038/s41598-018-20987-w.
9
The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation.
PLoS Pathog. 2017 Dec 29;13(12):e1006784. doi: 10.1371/journal.ppat.1006784. eCollection 2017 Dec.
10
Genomic and Proteomic Resolution of Heterochromatin and Its Restriction of Alternate Fate Genes.
Mol Cell. 2017 Dec 21;68(6):1023-1037.e15. doi: 10.1016/j.molcel.2017.11.030.
Zotero 插件